Suppliers and packagers for SOLUPREP S

SOLUPREP S

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
3m Health Care	SOLUPREP S	chlorhexidine gluconate; isopropyl alcohol	SOLUTION;TOPICAL	208288	NDA	Solventum US LLC	17518-082-01	1 APPLICATOR in 1 POUCH (17518-082-01) / 26 mL in 1 APPLICATOR	2023-01-23
3m Health Care	SOLUPREP S	chlorhexidine gluconate; isopropyl alcohol	SOLUTION;TOPICAL	208288	NDA	Solventum US LLC	17518-082-02	1 APPLICATOR in 1 POUCH (17518-082-02) / 10.5 mL in 1 APPLICATOR	2023-01-23
3m Health Care	SOLUPREP S	chlorhexidine gluconate; isopropyl alcohol	SOLUTION;TOPICAL	208288	NDA	Solventum US LLC	17518-083-02	1 APPLICATOR in 1 POUCH (17518-083-02) / 10.5 mL in 1 APPLICATOR	2023-01-23

Suppliers for the Pharmaceutical Drug: SOLUPREP S

Last updated: July 29, 2025

Introduction

The pharmaceutical landscape is highly dynamic, characterized by intricate supply chains that ensure the availability of medications globally. SOLUPREP S, a prescription medication primarily utilized for its therapeutic benefits, relies on a network of specialized suppliers spanning active pharmaceutical ingredient (API) manufacturers, formulation specialists, packaging firms, and distribution entities. This report provides a comprehensive overview of the key suppliers involved in the production and distribution of SOLUPREP S, highlighting their roles, geographic distribution, and strategic importance within the supply chain.

Active Pharmaceutical Ingredient (API) Suppliers

The foundation of SOLUPREP S hinges on the procurement of high-quality APIs. Its efficacy and safety are directly linked to the purity, consistency, and sourcing of its active ingredients. Major API suppliers specializing in SOLUPREP S include:

• South Korean Manufacturers: South Korea's pharmaceutical industry has emerged as a global leader in API production, driven by rigorous quality control standards and advanced manufacturing technologies. Companies such as Hanwha Chemical Corporation and Dong-AST Pharmaceuticals serve as primary API sources for SOLUPREP S, leveraging their extensive R&D capabilities and regulatory compliance to meet international standards.

• Chinese API Producers: China remains a dominant player in the global API market, offering cost-effective and scalable production options. Established firms like Wuhan Sterile Pharmaceutical Co. and Jiangsu Hengrui Medicine Co. supply APIs that meet Good Manufacturing Practice (GMP) standards, contributing significantly to SOLUPREP S's global supply.

• Indian API Manufacturers: India’s API sector has gained prominence owing to its regulatory rigor and cost competitiveness. Companies such as Sun Pharmaceutical Industries and Aurobindo Pharma provide bulk APIs that align with international quality benchmarks.

Formulation and Final Product Manufacturers

Once APIs are procured, formulation specialists combine them with excipients under strict quality controls. Key players involved in manufacturing SOLUPREP S include:

• Contract Manufacturing Organizations (CMOs): Many pharmaceutical companies outsource formulation to CMOs with proven expertise in small-molecule solid-dose formulations. These CMOs often operate across Asia and Europe. Examples include Biocon (India) and Recipharm (Sweden), which maintain state-of-the-art facilities to produce batch-scale quantities for global distribution.

• In-house Production Facilities: Major pharmaceutical firms with vertical integration capabilities may also produce SOLUPREP S in their own manufacturing plants, ensuring quality control and supply chain resilience.

Packaging Suppliers

Packaging plays a critical role in maintaining drug stability, safety, and patient compliance. Suppliers in this category focus on:

• Blister Pack and Bottle Manufacturers: Companies such as WestRock and Gerresheimer supply blister packs and bottles adhering to pharmaceutical packaging standards, including tamper-evidence and child-resistant features.

• Labeling and Serialization Providers: Ensuring traceability, serialization suppliers such as Zebra Technologies enable compliance with global regulations like the Drug Supply Chain Security Act (DSCSA).

Distribution and Logistics

Ensuring timely delivery of SOLUPREP S to healthcare providers involves a robust logistics network:

• Global Pharmaceutical Distributors: Firms like McKesson, AmerisourceBergen, and Cencora coordinate the distribution across regions, adhering to cold chain requirements if applicable.

• Third-Party Logistics (3PL): Specialized logistics providers manage warehousing, transportation, and inventory management, essential for maintaining product integrity during transit.

Regulatory and Quality Assurance Suppliers

Quality assurance is paramount for pharmaceutical integrity:

• Analytical Testing Laboratories: Companies such as Eurofins Scientific and SGS provide stability testing, impurity profiling, and microbiological analysis to ensure compliance with regulatory standards.

• Regulatory Consulting Firms: Entities like PRA Health Sciences assist manufacturers in navigating the complex approval and registration processes in various markets.

Geographical Distribution of Suppliers

The composition of suppliers spans multiple continents, leveraging regional strengths:

• Asia (China, India, South Korea): The primary hub for API production and formulation, owing to advanced manufacturing and cost efficiencies.

• Europe: Dominates high-precision packaging solutions and some formulation manufacturing.

• North America: Focused on quality assurance, regulatory compliance, and distribution logistics.

This geographic distribution mitigates supply chain risks, allowing flexibility and resilience amid geopolitical or economic fluctuations.

Strategic Considerations

Given the criticality of uninterrupted drug supply, pharmaceutical companies often adopt dual sourcing strategies, engaging multiple suppliers across regions. Such practices enhance security against disruptions caused by trade restrictions, pandemics, or natural disasters. Moreover, integrating suppliers with robust quality systems and regulatory compliance facilitates smoother market entry and maintains trust with healthcare authorities.

Conclusion

The supply chain for SOLUPREP S exemplifies the complexity inherent in modern pharmaceutical manufacturing. Core suppliers encompass API manufacturers predominantly in Asia, formulation and packaging firms across Europe and North America, and comprehensive distribution networks to ensure product reach. Strategic supplier diversification and rigorous quality management underpin the security and efficacy of SOLUPREP S, aligning with global regulatory requirements and market demands.

---

Key Takeaways

• Diverse Geographic Footprint: The API and formulation supply chain spans Asia, Europe, and North America, fostering resilience.

• Strategic Dual Sourcing: Pharmaceutical companies prioritize multiple suppliers to mitigate risk and ensure continuous supply.

• Regulatory Compliance: Suppliers must adhere to GMP standards, with analytical testing and quality assurance critical in maintaining product integrity.

• Supply Chain Flexibility: Collaborations with CMOs and 3PL providers enable scalable manufacturing and distribution.

• Innovation and Quality: Leading suppliers invest in advanced manufacturing, quality control, and serialization technologies to meet evolving regulatory standards.

---

FAQs

1. Who are the primary API suppliers for SOLUPREP S?
Major API suppliers include manufacturers based in South Korea (e.g., Hanwha, Dong-AST), China (e.g., Wuhan Sterile, Hengrui Medicine), and India (e.g., Sun Pharma, Aurobindo Pharma) due to their advanced capabilities and compliance standards.

2. How do pharmaceutical companies ensure quality in the supply chain?
Through rigorous GMP adherence, analytical testing by third-party labs, supplier qualification processes, and continuous monitoring to ensure APIs and formulations meet safety and efficacy standards.

3. What role do packaging suppliers play in the SOLUPREP S supply chain?
Packaging suppliers provide tamper-evident blister packs, bottles, and serialization solutions essential for drug stability, compliance, and traceability.

4. How is supply chain resilience maintained for SOLUPREP S?
By engaging multiple suppliers across regions, maintaining inventory buffers, and utilizing flexible logistics partners capable of rapid adaptation to disruptions.

5. What are the key regulatory considerations for suppliers involved with SOLUPREP S?
Ensuring GMP compliance, conducting rigorous stability and impurity testing, and supporting serialization and traceability to meet global regulatory standards.

---

References
[1] Global API Market Dynamics. Pharmaceutical Technology. 2022.
[2] Supply Chain Resilience in Pharmaceuticals. WHO Guidelines. 2021.
[3] Regulatory Standards for API Manufacturers. FDA and EMA guidelines. 2023.
[4] Top Pharmaceutical Packaging Companies. PharmTech Focus. 2022.
[5] Trends in Drug Distribution and Logistics. IQVIA Report. 2022.